Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide.

about

Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide.

Item

http://www.wikidata.org/entity/Q55184664

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Oral Ferric Citrate Hydrate As ...... nous Saccharated Ferric Oxide.

@en

Oral Ferric Citrate Hydrate As ...... nous Saccharated Ferric Oxide.

@nl

type

Item

label

Oral Ferric Citrate Hydrate As ...... nous Saccharated Ferric Oxide.

@en

Oral Ferric Citrate Hydrate As ...... nous Saccharated Ferric Oxide.

@nl

prefLabel

Oral Ferric Citrate Hydrate As ...... nous Saccharated Ferric Oxide.

@en

Oral Ferric Citrate Hydrate As ...... nous Saccharated Ferric Oxide.

@nl

P1476

Oral Ferric Citrate Hydrate As ...... enous Saccharated Ferric Oxide

@en

P2093

Hideki Hirakata

http://www.w3.org/2001/XMLSchema#string

Keitaro Yokoyama

http://www.w3.org/2001/XMLSchema#string

Kimio Watanabe

http://www.w3.org/2001/XMLSchema#string

Masaaki Nakayama

http://www.w3.org/2001/XMLSchema#string

Myles Wolf

http://www.w3.org/2001/XMLSchema#string

Takashi Akiba

http://www.w3.org/2001/XMLSchema#string

Wan-Jun Zhu

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Tani

http://www.w3.org/2001/XMLSchema#string

P2860

Parenteral versus oral iron therapy for adults and children with chronic kidney disease

Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century

How the Target Hemoglobin of Renal Anemia Should Be

Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials

Mechanisms of anemia in CKD.

Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality.

Effect of α -Lipoic Acid on Oxidative Stress in End-Stage Renal Disease Patients Receiving Intravenous Iron.

Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients.

Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: An Updated Systematic Review and Meta-analysis.

Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.

P304

364-373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EKIR.2017.10.016

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Masafumi Fukagawa

P577

2017-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29725640

http://www.w3.org/2001/XMLSchema#string

P921

ferric citrate monohydrate

P932

5932126

http://www.w3.org/2001/XMLSchema#string